drugset / Trial / NCT03106870
Adding Metformin to Insulin in Controlling Pregestational and Gestational Diabetes Mellitus
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of the study to prove benefits of adding metformin to insulin for controlling presentational and gestational diabetes mellitus and improving neonatal outcome.
Timeline
- Start
- 2016-06
- Primary completion
- 2016-12
- Completion
- 2016-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Metformin | Small molecule | 1500 mg | Oral |
| Comparator | Insulin Mixtard | Unknown | 0.8 iu/kg | — |